ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors.
Ciró M, Prosperini E, Quarto M, Grazini U, Walfridsson J, McBlane F, Nucifero P, Pacchiana G, Capra M, Christensen J, Helin K.
Ciró M, et al. Among authors: christensen j.
Cancer Res. 2009 Nov 1;69(21):8491-8. doi: 10.1158/0008-5472.CAN-09-2131. Epub 2009 Oct 20.
Cancer Res. 2009.
PMID: 19843847